Zentalis Pharmaceuticals, Inc.
USD4.61
+0.57 (+14.11%)
CEO
Julia Marie Eastland
IPO Date
2020-04-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.01
Prev. Close
$4.04
Day Low
$3.96
Day High
$4.88
52W Low
$1.13
52W High
$6.95
Market Cap
$0.33B
Volume
2.75M
| 57,100 |
| $0.00 |
| 18 Jun 2026 | Walker Luke Nathaniel | director | A-Award | Acquired | 57,100 | $0.00 |
| 18 Jun 2026 | Kariuki Enoch | director | A-Award | Acquired | 57,100 | $0.00 |
| 18 Jun 2026 | Myers Scott Dunseth | director | A-Award | Acquired | 57,100 | $0.00 |
| 27 May 2026 | Campbell Shannon | director | A-Award | Acquired | 114,200 | $0.00 |
| 27 May 2026 | Campbell Shannon | director: | Disposed | 0 | $0.00 |
| 10 Feb 2026 | Bruns Ingmar | Chief Medical Officer | S-Sale | Disposed | 335 | $2.39 |
| 10 Feb 2026 | Bruns Ingmar | Chief Medical Officer | S-Sale | Disposed | 2,962 | $2.43 |
| 10 Feb 2026 | Vultaggio Vincent | PAO and PFO | S-Sale | Disposed | 29,951 | $2.43 |